Last quarter (Q4 2023), Ascendis Pharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Ascendis Pharma's net income was $―. See Ascendis Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 21.45M	$ 266.72M	$ 51.17M	$ 7.78M	$ 6.95M	$ 13.38M
Cost of Revenue	$ 2.78M	$ 44.40M	$ 12.14M	$ 3.52M	$ 0.00	$ ―
Gross Profit	$ 18.67M	$ 222.32M	$ 39.04M	$ 4.25M	$ 6.95M	$ ―
Operating Expense	$ 305.07M	$ 677.86M	$ 600.85M	$ 456.05M	$ 337.57M	$ 240.09M
Operating Income	$ -286.40M	$ -455.54M	$ -561.81M	$ -451.79M	$ -330.62M	$ -226.72M
Net Non Operating Interest Income Expense	$ 40.77M	$ 16.86M	$ 52.18M	$ 59.72M	$ -106.00K	$ 8.84M
Other Income Expense	$ -4.86M	$ 3.74M	$ 68.18M	$ -15.90M	$ -88.45M	$ -366.00K
Pretax Income	$ -250.49M	$ -474.14M	$ -577.82M	$ -380.09M	$ -419.17M	$ -218.25M
Tax Provision	$ -214.00K	$ 7.30M	$ 5.38M	$ -367.00K	$ -219.00K	$ -234.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ -18.39M	$ -17.70M	$ 12.04M	$ ―	$ ―
Net Income Common Stockholders	$ -250.27M	$ -481.45M	$ -583.19M	$ -379.72M	$ -418.95M	$ -218.02M
Basic EPS	$ -4.49	$ -8.55	$ ―	$ ―	$ -8.28	$ -4.69
Diluted EPS	$ -4.49	$ -8.55	$ ―	$ ―	$ -8.28	$ -4.69
Basic Average Shares	$ 111.64M	$ 56.29M	$ 56.07M	$ 54.77M	$ 50.62M	$ 46.51M
Diluted Average Shares	$ 111.64M	$ 56.29M	$ 56.07M	$ 54.77M	$ 50.62M	$ 46.51M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 307.85M	$ 722.26M	$ 612.99M	$ 459.57M	$ 337.57M	$ 240.09M
Net Income From Continuing And Discontinued Operation	$ -250.27M	$ -481.45M	$ -583.19M	$ -379.72M	$ -418.95M	$ -218.02M
Normalized Income	$ -250.27M	$ ―	$ ―	$ ―	$ -340.07M	$ -225.75M
Interest Expense	$ 50.68M	$ ―	$ ―	$ ―	$ 1.92M	$ 1.22M
EBIT	$ -199.81M	$ ―	$ -608.50M	$ -384.00M	$ -417.26M	$ -217.03M
EBITDA	$ -190.90M	$ ―	$ -590.54M	$ -368.61M	$ -407.81M	$ -210.34M

Currency in USD

Ascendis Pharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing